Stockreport

UPDATE 2-Alnylam's gene-silencing efforts get $2 bln Blackstone backing [Reuters]

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview
PDF Blackstone invests $2 billion in Alnylam, boosting gene-silencing drug development (Reuters) - Blackstone Group Inc said on Monday it invested $2 billion in Alnylam Phar [Read more]